Hanmi Pharm Signs Exclusive Licensing Deal with Genentech for Novel Obesity Therapy HM17321, a proprietary UCN2 (urocortin-2) analog, is being developed as a treatment… CISION PRNewswireAugust 24, 2026
IBM Study: Sports Fans Want Streamlined Digital Experiences as Platform Choices Expand AI use among surveyed sports fans increased in 2026, with accuracy driving… CISION PRNewswireAugust 24, 2026
IBM and the USTA Introduce New AI-Powered Fan Experiences for 2026 US Open NEW YORK, Aug. 24, 2026 /PRNewswire/ — IBM (NYSE: IBM) and the… CISION PRNewswireAugust 24, 2026
Press ReleaseNew US$22 Million Education Lifeline for Crisis-Affected Children in Sudan New three-year investment will reach nearly 200,000 crisis-affected children and adolescents, helping… CISION PRNewswireAugust 24, 2026
Press ReleaseSoftcare Reports 46% Interim Profit Growth as Emerging-Market Momentum Continues, Payout Ratio Rises to Approximately 66% HONG KONG, Aug. 24, 2026 /PRNewswire/ — Softcare Limited ("Softcare" or the… CISION PRNewswireAugust 24, 2026
Press ReleaseLONGi at UNCCD COP17: Li Zhenguo Explains Two Technological Pathways for PV-Powered Food Security ULAANBAATAR, Mongolia, Aug. 24, 2026 /PRNewswire/ — From August 17 to 28,… CISION PRNewswireAugust 24, 2026
Press ReleaseOneSG61 with Antica Unites Community Inclusion, Youth Development and International Sporting Excellence Two-day community carnival and the Inaugural ANTICA Singapore International Challenge 2026 bring… CISION PRNewswireAugust 24, 2026
Press Releaseimin Pursues White-Label Partnerships to Expand into Japan, Taiwan and Southeast Asia Twave, operator of imin: "In discussions with financial groups and digital banks… CISION PRNewswireAugust 24, 2026